
(AGENPARL) – BRUXELLES mer 29 giugno 2022 Since its adoption, EU legislation on blood, tissues and cells has ensured an upward convergence in the quality and safety of these substances from donation to human application. Following an evaluation of the legislation, shortcomings have become apparent, primarily in light of scientific and technical developments in this area. Socio-demographic trends and new epidemiological risks have further consolidated the view that certain provisions of this legislation need to better reflect the current landscape. Moreover, effective protection of donors needs to be placed on the same level as that of recipients, in particular in the case of medically assisted reproduction. Finally, in light of the coronavirus pandemic, ensuring sufficient supplies of these substances has become all the more significant. On this basis, the European Commission launched a revision of this legal framework, which is expected to be adopted in the second quarter of 2022.
Fonte : © Unione europea, 2022 – PE
Fonte/Source: https://www.europarl.europa.eu/thinktank/it/document/EPRS_BRI(2022)699492